摘要
背景:颅内出血的特征在于血管破裂和随后的血肿扩张。 它是最不可治疗的中风亚型,导致比缺血性中风更高的发病率和死亡率。 近期研究观察到脑内出血患者血浆纤维蛋白原水平低于正常水平。 此外,在其他严重出血的情况下,血浆纤维蛋白原水平已被确定为预后指标。 目前脑出血的临床治疗包括辅助治疗和可能的手术撤离。 然而,颅内出血的可能治疗靶点是纤维蛋白原。 在血肿扩张的颅内出血期间,纤维蛋白原水平迅速消耗,因此需要更换。 维持高水平的纤维蛋白原可以促进凝血快速和血肿扩张减少。 目的:在本综述中,我们检查纤维蛋白原在颅内出血中的作用,并评估使用纤维蛋白原替代疗法维持正常水平的这种关键止血蛋白。 讨论优点和缺点,并对颅内出血最合适的纤维蛋白原替代疗法做出意见。 结论:纤维蛋白原浓缩物似乎是提升血浆纤维蛋白原治疗血肿扩大的颅内出血最合适的治疗方法。
关键词: 纤维蛋白原,纤维蛋白原浓缩物,纤维蛋白原冷冻沉淀物,脑内出血,蛛网膜下腔出血,生发基质出血。
图形摘要
Current Drug Targets
Title:Maintaining Plasma Fibrinogen Levels and Fibrinogen Replacement Therapies for Treatment of Intracranial Hemorrhage
Volume: 18 Issue: 12
关键词: 纤维蛋白原,纤维蛋白原浓缩物,纤维蛋白原冷冻沉淀物,脑内出血,蛛网膜下腔出血,生发基质出血。
摘要: Background: Intracranial hemorrhage is characterized by the blood vessel rupture and subsequent hematoma expansion. It is the least treatable stroke subtype, resulting in higher morbidity and mortality per incidence than ischemic stroke. Recent studies have observed lower than normal levels of plasma fibrinogen in patients of intracerebral hemorrhage. Furthermore, in other cases of severe hemorrhage, plasma fibrinogen levels have been identified as an indicator of prognosis. Current clinical management of cerebral hemorrhage includes adjunctive therapies and possible surgical evacuation. However, a possible therapeutic target for intracranial hemorrhage is fibrinogen. During intracranial hemorrhage with hematoma expansion, fibrinogen levels are rapidly depleted and thus are in need of replacement. Maintaining high levels of fibrinogen can promote rapid clotting and reduction of hematoma expansion.
Objectives: Within this review, we examine the role of fibrinogen in intracranial hemorrhage and evaluate the use of fibrinogen replacement therapies for maintaining normal levels of this key hemostatic protein. The pros and cons are discussed and an opinion of the most appropriate fibrinogen replacement therapy for intracranial hemorrhage is made. Conclusion: It is concluded that fibrinogen concentrate seems to be the most suitable therapy for elevating plasma fibrinogen for the treatment of intracranial hemorrhage with hematoma expansion.Export Options
About this article
Cite this article as:
Maintaining Plasma Fibrinogen Levels and Fibrinogen Replacement Therapies for Treatment of Intracranial Hemorrhage, Current Drug Targets 2017; 18 (12) . https://dx.doi.org/10.2174/1389450117666151209123857
DOI https://dx.doi.org/10.2174/1389450117666151209123857 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Renal Nerve Ablation for Hypertensive Patients with Chronic Kidney Disease
Current Vascular Pharmacology Sex Differences in Biomarkers for Predicting Cardiovascular and Coronary Events
Current Vascular Pharmacology Contribution of Platelet-Derived CD40 Ligand to Inflammation, Thrombosis and Neoangiogenesis
Current Medicinal Chemistry Patterns of Acute Intracranial Hemorrhage in Adult Patients with Bilateral and Unilateral Moyamoya Disease
Current Neurovascular Research A Novel, Biodegradable, Thermoresponsive Hydrogel Attenuates Ventricular Remodeling and Improves Cardiac Function Following Myocardial Infarction - a review
Current Pharmaceutical Design Mast Cells in Abdominal Aortic Aneurysms
Current Vascular Pharmacology Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions
Current Neuropharmacology Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy
Current Pharmaceutical Design Q Fever Endocarditis
Infectious Disorders - Drug Targets T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Coronary Intravascular Ultrasound (IVUS): Contemporary Applications and Bases for the Future
Recent Patents on Medical Imaging CCR2 Antagonists
Current Topics in Medicinal Chemistry Implantable Medical Devices and Tissue Engineering: An Overview of Manufacturing Processes and the Use of Polymeric Matrices for Manufacturing and Coating their Surfaces
Current Medicinal Chemistry Imaging Features of Thoracic Manifestations of Behçet’s Disease: Beyond Pulmonary Artery Involvement
Current Medical Imaging Fluorescein Fluorescence Use in the Management of Intracranial Neoplastic and Vascular Lesions: A Review and Report of a New Technique
Current Drug Discovery Technologies Brain Drug Delivery Systems for the Stroke Intervention and Recovery
Current Pharmaceutical Design Endothelial Dysfunction and Coronary Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Injectable <i>In-Situ</i> Forming Depot of Doxycycline Hyclate/α-Cyclodextrin Complex Using PLGA for Periodontitis Treatment: Preparation, Characterization, and <i>In-Vitro</i> Evaluation
Current Drug Delivery Estrogenic Compounds, Estrogen Receptors and Vascular Cell Signaling in the Aging Blood Vessels
Current Medicinal Chemistry Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Current Cardiology Reviews